{
  "symbol": "EOG",
  "year": 2024,
  "Period": "Q3",
  "report_type": "Q10",
  "metrics": {
    "mdna_sentiment": -0.2732,
    "outlook_sentiment": 0.1142,
    "forward_ratio": 1.0,
    "hedge_ratio": 0.15
  },
  "top_positive": [
    {
      "sent": "UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS The following table sets forth, for the periods indicated, EOG's share repurchase activity: Period Total Number of Shares Purchased (1) Average Price Paid Per Share Total Value of Shares Purchased as Part of Publicly Announced Plans or Programs (2) Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (2)(3) January 1, 2024 - January 31, 2024 892,971 $ 112.19 $ 99,115,064 $ 3,929,752,660 February 1, 2024 - February 29, 2024 1,375,357 113.58 153,137,935 $ 3,776,614,725 March 1, 2024 - March 31, 2024 4,177,716 120.35 497,762,098 $ 3,278,852,627 Total 6,446,044 117.77 750,015,097 (1) Includes 6,369,617 shares repurchased during the quarter ended March 31, 2024, at an average price of $117.75 per share (inclusive of commissions and transaction fees), pursuant to the November 2021 Authorization (as defined and further discussed below); such repurchases count against the November 2021 Authorization.",
      "score": 0.9609
    },
    {
      "sent": "UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS The following table sets forth, for the periods indicated, EOG's share repurchase activity: Period Total Number of Shares Purchased (1) Average Price Paid Per Share Total Value of Shares Purchased as Part of Publicly Announced Plans or Programs (2) Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (2)(3) January 1, 2024 - January 31, 2024 892,971 $ 112.19 $ 99,115,064 $ 3,929,752,660 February 1, 2024 - February 29, 2024 1,375,357 113.58 153,137,935 $ 3,776,614,725 March 1, 2024 - March 31, 2024 4,177,716 120.35 497,762,098 $ 3,278,852,627 Total 6,446,044 117.77 750,015,097 (1) Includes 6,369,617 shares repurchased during the quarter ended March 31, 2024, at an average price of $117.75 per share (inclusive of commissions and transaction fees), pursuant to the November 2021 Authorization (as defined and further discussed below); such repurchases count against the November 2021 Authorization.",
      "score": 0.9609
    },
    {
      "sent": "Based on this evaluation, EOG's principal executive officer and principal financial officer have concluded that EOG's disclosure controls and procedures were effective as of the Evaluation Date in ensuring that information that is required to be disclosed in the reports EOG files or furnishes under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the United States Securities and Exchange Commission's rules and forms and (ii) accumulated and communicated to EOG's management, as appropriate, to allow timely decisions regarding required disclosure.",
      "score": 0.8779
    }
  ],
  "top_negative": [
    {
      "sent": "EOG's exposure to commodity price risk, interest rate risk and foreign currency exchange rate risk is discussed in (i) the \"Financial Commodity Derivative Transactions,\" \"Financing\" and \"Outlook\" sections of \"Management's Discussion and Analysis of Financial Condition and Results of Operations - Capital Resources and Liquidity\" included in EOG's Annual Report on Form 10-K for the year ended December 31, 2023, filed on February 22, 2024 (EOG's 2023 Annual Report); and (ii) Note 12, \"Risk Management Activities,\" to EOG's Consolidated Financial Statements included in EOG's 2023 Annual Report.",
      "score": -0.5267
    },
    {
      "sent": "There were no changes in EOG's internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) promulgated under the Exchange Act) that occurred during the quarterly period covered by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, EOG's internal control over financial reporting.",
      "score": -0.4215
    },
    {
      "sent": "The November 2021 Authorization has no time limit, does not require EOG to repurchase a specific number of shares and may be modified, suspended or terminated by the Board at any time.",
      "score": -0.4215
    }
  ],
  "forward_snippets": [
    "EOG's exposure to commodity price risk, interest rate risk and foreign currency exchange rate risk is discussed in (i) the \"Financial Commodity Derivative Transactions,\" \"Financing\" and \"Outlook\" sections of \"Management's Discussion and Analysis of Financial Condition and Results of Operations - Capital Resources and Liquidity\" included in EOG's Annual Report on Form 10-K for the year ended December 31, 2023, filed on February 22, 2024 (EOG's 2023 Annual Report); and (ii) Note 12, \"Risk Management Activities,\" to EOG's Consolidated Financial Statements included in EOG's 2023 Annual Report.",
    "Description 3.1(a) - Restated Certificate of Incorporation, dated September 3, 1987 (\nOutlook\" sections of \"Management's Discussion and Analysis of Financial Condition and Results of Operations - Capital Resources and Liquidity\" included in EOG's Annual Report on Form 10-K for the year ended December 31, 2023, filed on February 22, 2024 (EOG's 2023 Annual Report); and (ii) Note 12, \"Risk Management Activities,\" to EOG's Consolidated Financial Statements included in EOG's 2023 Annual Report."
  ]
}